Stocksigma LogoStocksigma Logo

Arvaya Healthcare Q2 FY27 Consolidated Financial Results and Strategic Updates

Arvaya Healthcare reported Q2 ended 30th Sep'26 consolidated revenue of ₹40.28 cr (vs ₹29.91 cr in Q1) and net profit of ₹1.37 cr (vs ₹0.53 cr in Q1)

Arvaya Healthcare Q2 FY27 Consolidated Financial Results and Strategic Updates

Bijoy Hans Ltd · Financial Result · 14 Nov 2026, 1:04 am

Arvaya Healthcare Q2 FY27 Consolidated Financial Results and Strategic Updates Arvaya Healthcare reported Q2 ended 30th Sep'26 consolidated revenue of ₹40.28 cr (vs ₹29.91 cr in Q1) and net profit of ₹1.37 cr (vs ₹0.53 cr in Q1). Standalone Q2 revenue was ₹0.91 cr with a net loss of ₹0.46 cr. Post-quarter on 1st Nov'26, the company completed the 100% acquisition of Sushodha Institute of Gastroenterology via a share swap, allotting 38.72 lakh equity shares on 24th Oct'26. Additionally, the board progressed a proposed rights issue of partly paid-up equity shares aggregating up to ₹210 cr.

Original exchange filing (PDF)

More announcements from Bijoy Hans Ltd

All Bijoy Hans Ltd announcements